Evidence map›Paper›PMID 31409988›Full record

ArticleInternational journal of nanomedicine2019

Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models.

Kalaimathi Murugesan, Jinsha Koroth, Padma Priya Srinivasan, Amrita Singh, Sanjana Mukundan, Subhas S Karki, Bibha Choudhary, Chhitar M Gupta

RetractedErratum issuedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Metal-based nanoparticle in cancer treatment: lessons learned and challenges.Frontiers in bioengineering and biotechnology · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Applications of Gold and Silver Nanoparticles in Theranostics.Applied biochemistry and biotechnology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. UsingRSC advances · 2020
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kalaimathi Murugesan *Institute of Bioinformatics and Applied Biotechnology (IBAB) , Bangalore, India.
Jinsha Koroth *Institute of Bioinformatics and Applied Biotechnology (IBAB) , Bangalore, India.
Padma Priya SrinivasanInstitute of Bioinformatics and Applied Biotechnology (IBAB) , Bangalore, India.
Amrita SinghWater Analysis Laboratory, Nanomaterial Toxicology Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India.
Sanjana MukundanInstitute of Bioinformatics and Applied Biotechnology (IBAB) , Bangalore, India.
Subhas S KarkiKLE Academy of Higher Education & Research, KLE College of Pharmacy, Bangalore, KN, India.
Bibha ChoudharyInstitute of Bioinformatics and Applied Biotechnology (IBAB) , Bangalore, India.
Chhitar M GuptaInstitute of Bioinformatics and Applied Biotechnology (IBAB) , Bangalore, India.
Institute of Bioinformatics and Applied Biotechnology · INIndian Institute of Toxicology Research · INKLE University · INManipal Academy of Higher Education · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, green synthesized silver nanoparticles have been increasingly investigated for their anti-cancer potential. In the present study, we aimed at the biosynthesis of silver nanoparticles (AgNPs) using a curcumin derivative, ST06. Although, the individual efficacies of silver nanoparticles or curcumin derivatives have been studied previously, the synergistic cytotoxic effects of curcumin derivative and silver nanoparticles in a single nanoparticulate formulation have not been studied earlier specifically on animal models. This makes this study novel compared to the earlier synthesized curcumin derivative or silver nanoparticles studies. The aim of the study was to synthesize ST06 coated silver nanoparticles (ST06-AgNPs) using ST06 as both reducing and coating agent.

methodsThe synthesized nanoparticles AgNPs and ST06-AgNPs were characterised for the particle size distribution, morphology, optical properties and surface charge by using UV-visible spectroscopy, dynamic light scattering (DLS) and transmission electron microscopy (TEM). Elemental composition and structural properties were studied by energy dispersive X-ray spectroscopy (EDX) and X-ray diffraction spectroscopy (XRD). The presence of ST06 as capping agent was demonstrated by Fourier transform infrared spectroscopy (FTIR).

resultsThe synthesized nanoparticles (ST06-AgNPs) were spherical and had a size distribution in the range of 50-100 nm. UV-Vis spectroscopy displayed a specific silver plasmon peak at 410 nm. The in vitro cytotoxicity effects of ST06 and ST06-AgNPs, as assessed by MTT assay, showed significant growth inhibition of human cervical cancer cell line (HeLa). In addition, studies carried out in EAC tumor-induced mouse model (Ehrlich Ascites carcinoma) using ST06-AgNPs, revealed that treatment of the animals with these nanoparticles resulted in a significant reduction in the tumor growth, compared to the control group animals.

conclusionIn conclusion, green synthesized ST06-AgNPs exhibited superior anti-tumor efficacy than the free ST06 or AgNPs with no acute toxicity under both in vitro and in vivo conditions. The tumor suppression is associated with the intrinsic apoptotic pathway. Together, the results of this study suggest that ST06-AgNPs could be considered as a potential option for the treatment of solid tumors.

Indexed as

AnimalsApoptosisCarcinoma, Ehrlich TumorCaspase 3Caspase 9Cell DeathCurcuminDisease Models, AnimalFemaleGreen Chemistry TechnologyHeLa CellsHumansMetal NanoparticlesMiceParticle SizePoly(ADP-ribose) PolymerasesCaspase 3Caspase 9CurcuminPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-bcl-2SilveranticancerapoptosisEhrlich Ascites carcinomasilver nanoparticles

Identifiers

PMID31409988
PMCPMC6646051
OpenAlexW2960083904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.